Covid-19 antiviral drug Molnupiravir launched in India for moderate infection

0
45

Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for a five-day course for mild to moderate infection.

Amid rising cases of new Covid variant Omicron in the country, an expert panel of the Central Drugs Standard Control Organisation had recently approved antiviral drug Molnupiravir for restricted use in emergency situation.

Along with Molnupiravir, the CDSCO has also granted emergency use authorisation to the Serum Institute of India’s Covid vaccine COVOVAX, Hyderabad based Biological E RBD Protein CORBEVAX.

Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. The recommended dose of Molnupiravir 800 mg is twice a day for five days. A patient needs to take 40 capsules containing 200 mg of medication. Over a dizen pharma companies including Torrent, Cipla, Sun Pharma, Dr Reddy’s, Natco, Mylan, and Hetero are in the process to manufacture the oral pill.

Cipla, Sun Pharma, and Dr Reddy’s Laboratories are also expected to release Molnupiravir capsules in the coming weeks.

Molnupiravir, developed by MSD and Ridgeback Biotherapeutics, is also the first oral anti-Covid pill approved by UK’s drug regulator. The US Food and Drug Administration (USFDA) has also cleared Molnupiravir for the treatment of mild-to-moderate Covid-19 in adults, and for those who are at a high risk to severe disease.

Previous articleAmit Shah reviews security situation, threats from terror groups
Next articleAries Weekly Horoscope 2nd January – 9th January 2022
Arushi Sana
Arushi Sana is the Co-Founder of Santerra Living, a bio-pellet factory that makes a renewable form of eco-coal and Co-Founder of NYK Daily, a global news platform. She was awarded the Times Power Women of the Year 2022, Times Digital Entrepreneur of the Year 2023, Silicon India's Top 10 Women Owned Startups of Hyderabad 2023 and IHW Council Climate Health Influencer 2024. Arushi is also a speaker for Sustainability and Entrepreneurship at various forms like the World Bank, UN International Solar Alliance and Universities, and was also invited to the UN COP28 UAE Climate Conference. She is a Sustainability Consultant for organisations looking to reduce their carbon footprint and also works with brands on social media to help them carve a presence in that niche. She holds a Degree in Computer Science Engineering from VIT University and a Diploma in Marketing Analytics from IIM Nagpur. She has previously worked in Ernst & Young and Deloitte as a Forensic Data Analyst. Arushi is a writer, political researcher, a social worker, a farmer and a singer with an interest in languages. Travel and nature are the biggest spiritual getaways for her, and she aims to develop a global community of knowledge and journalism par excellence through this News Platform.

Was it worth reading? Let us know.